For a general timeline of the Bayh-Dole Act, see this page. 1980. December 12. The Bayh-Dole Act was enacted into law as part of Public Law 96-517, including Section 203 that provide march-in rights. 1984. November 8. The Bayh-Dole statute was… Continue Reading →
This is an update to a 2007 report regarding a district court decision in the Innogenetics v. Abbott case here, regarding Abbott’s infringement of Innogenetics’s patents for HCV genotyping. The previous blog discusses the ruling at the district court level… Continue Reading →
Prices for Abbott’s Norvir (generic name Ritonavir) as a Standalone Product in 2010 KEI Research Note 2010:4 August 12, 2010 Anne Mira Guha Prices for Abbott’s Norvir (generic name Ritonavir) as a Standalone Product in 2010 1. Introduction Ritonavir is… Continue Reading →
In 2007, Thailand was involved in a dispute over the granting of compulsory licenses on medicines, including the patents used for Kaletra, an Abbott drug used in the treatment of AIDS. Kaletra is the brand name for a fixed dose combination of lopinavir and ritonavir (LPV/r) — two drugs invented at Abbott on an NIH grant. In 2007, LPV/r was the preferred combination for protease inhibitor regimes used to treat AIDS. Continue Reading →
Monday, 30 April 2007 “The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites.” The following is the… Continue Reading →
On Friday, March 16, KEI organized a briefing in the U.S. Capitol on Thailand’s recent compulsory licenses on three drugs; two for HIV/AIDS (Merck’s efavirenz (Stocrin) and Abbott’s lopinavir + ritonavir (Kaletra)) and one for heart disease (Sanofi’s clopidogrel (Plavix)). … Continue Reading →
R 131556Z – October 13, 2005FM AMEMBASSY BRAZILIATO SECSTATE WASHDC 3176SUBJECT: ABBOTT AND GOB REACH DEAL TO AVOID COMPULSORY LICENSE 1. SENSITIVE BUT UNCLASSIFIED – PLEASE TREAT ACCORDINGLY 2. (U) Summary. On October 10, Abbott Laboratories and Brazil’s Ministry of… Continue Reading →
R 281104Z JUN 05 – June 28, 2005FM AMEMBASSY BRASILIATO SECSTATE WASHDC 1902SUBJECT: BRAZIL GIVES ABBOTT TEN DAYS BEFORE BREAKING PATENT 1. (U) SENSITIVE BUT UNCLASSIFIED 2. (U) Summary. On Friday June 24, the GoB announced a declaration of “public… Continue Reading →